$239.54
0.09%
Downside
Day's Volatility :1.87%
Upside
1.79%
25.84%
Downside
52 Weeks Volatility :31.11%
Upside
7.1%
Period | Teleflex Incorporated | Sector (Health Care) | S&P500 |
---|---|---|---|
3 Months | 16.97% | 7.5% | 3.1% |
6 Months | 15.17% | 6.9% | 9.6% |
1 Year | 27.77% | 20.9% | 35.0% |
3 Years | -33.93% | 21.0% | 31.0% |
Market Capitalization | 11.6B |
Book Value | $96.76 |
Dividend Share | 1.36 |
Dividend Yield | 0.55% |
Earnings Per Share (EPS) | 5.58 |
PE Ratio | 44.23 |
PEG Ratio | 1.32 |
Wall Street Target Price | 261.45 |
Profit Margin | 8.76% |
Operating Margin TTM | 16.64% |
Return On Assets TTM | 3.27% |
Return On Equity TTM | 6.03% |
Revenue TTM | 3.0B |
Revenue Per Share TTM | 63.91 |
Quarterly Revenue Growth YOY | 0.8999999999999999% |
Gross Profit TTM | 1.6B |
EBITDA | 630.6M |
Diluted Eps TTM | 5.58 |
Quarterly Earnings Growth YOY | -0.28 |
EPS Estimate Current Year | 13.97 |
EPS Estimate Next Year | 15.41 |
EPS Estimate Current Quarter | 3.33 |
EPS Estimate Next Quarter | 3.41 |
What analysts predicted
Upside of 9.15%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 2.4B | ↑ 14.07% |
Net Income | 200.8M | ↑ 31.65% |
Net Profit Margin | 8.2% | ↑ 1.09% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 2.6B | ↑ 6.0% |
Net Income | 461.5M | ↑ 129.81% |
Net Profit Margin | 17.78% | ↑ 9.58% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 2.5B | ↓ 2.24% |
Net Income | 335.3M | ↓ 27.34% |
Net Profit Margin | 13.22% | ↓ 4.56% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 2.8B | ↑ 10.74% |
Net Income | 485.4M | ↑ 44.75% |
Net Profit Margin | 17.28% | ↑ 4.06% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 2.8B | ↓ 0.66% |
Net Income | 363.1M | ↓ 25.18% |
Net Profit Margin | 13.01% | ↓ 4.27% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 3.0B | ↑ 6.57% |
Net Income | 356.3M | ↓ 1.88% |
Net Profit Margin | 11.98% | ↓ 1.03% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 710.9M | ↓ 6.21% |
Net Income | 76.7M | ↓ 2.34% |
Net Profit Margin | 10.8% | ↑ 0.43% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 743.3M | ↑ 4.55% |
Net Income | 111.3M | ↑ 45.07% |
Net Profit Margin | 14.98% | ↑ 4.18% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 746.4M | ↑ 0.42% |
Net Income | 137.1M | ↑ 23.18% |
Net Profit Margin | 18.37% | ↑ 3.39% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 773.9M | ↑ 3.69% |
Net Income | 31.1M | ↓ 77.32% |
Net Profit Margin | 4.02% | ↓ 14.35% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 737.8M | ↓ 4.66% |
Net Income | 15.3M | ↓ 50.85% |
Net Profit Margin | 2.07% | ↓ 1.95% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Revenue | 749.7M | ↑ 1.6% |
Net Income | 80.0M | ↑ 423.5% |
Net Profit Margin | 10.68% | ↑ 8.61% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 6.3B | ↑ 1.56% |
Total Liabilities | 3.7B | ↓ 0.35% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 6.3B | ↑ 0.51% |
Total Liabilities | 3.3B | ↓ 10.9% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 7.2B | ↑ 13.36% |
Total Liabilities | 3.8B | ↑ 14.58% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 6.9B | ↓ 3.93% |
Total Liabilities | 3.1B | ↓ 18.32% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 6.9B | ↑ 0.82% |
Total Liabilities | 2.9B | ↓ 6.77% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 7.5B | ↑ 8.73% |
Total Liabilities | 3.1B | ↑ 6.38% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 6.9B | ↓ 0.15% |
Total Liabilities | 2.8B | ↓ 3.39% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 6.9B | ↓ 0.32% |
Total Liabilities | 2.7B | ↓ 4.52% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 7.5B | ↑ 8.67% |
Total Liabilities | 3.2B | ↑ 18.61% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 7.5B | ↑ 0.52% |
Total Liabilities | 3.1B | ↓ 2.77% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 7.5B | ↓ 0.73% |
Total Liabilities | 3.0B | ↓ 3.78% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 7.4B | ↓ 0.49% |
Total Liabilities | 2.9B | ↓ 3.09% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 437.4M | ↑ 4.17% |
Investing Cash Flow | -196.4M | ↓ 89.28% |
Financing Cash Flow | -206.4M | ↓ 118.09% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 439.5M | ↑ 0.49% |
Investing Cash Flow | -73.5M | ↓ 62.58% |
Financing Cash Flow | -418.8M | ↑ 102.89% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 436.4M | ↓ 0.71% |
Investing Cash Flow | -837.8M | ↑ 1040.14% |
Financing Cash Flow | 455.2M | ↓ 208.67% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 651.4M | ↑ 49.27% |
Investing Cash Flow | 156.7M | ↓ 118.71% |
Financing Cash Flow | -715.8M | ↓ 257.27% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 342.1M | ↓ 47.48% |
Investing Cash Flow | -257.9M | ↓ 264.57% |
Financing Cash Flow | -217.5M | ↓ 69.61% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 84.1M | ↓ 14.4% |
Investing Cash Flow | -21.9M | ↓ 91.51% |
Financing Cash Flow | -93.6M | ↑ 446.26% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 86.1M | ↑ 2.42% |
Investing Cash Flow | -7.3M | ↓ 66.53% |
Financing Cash Flow | -92.4M | ↓ 1.27% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 201.6M | ↑ 134.17% |
Investing Cash Flow | -57.7M | ↑ 687.26% |
Financing Cash Flow | 462.0M | ↓ 600.04% |
Sell
Neutral
Buy
Teleflex Incorporated is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Teleflex Incorporated | 1.01% | 15.17% | 27.77% | -33.93% | -25.59% |
Intuitive Surgical, Inc. | 1.62% | 28.13% | 70.56% | 51.86% | 183.93% |
Resmed Inc. | -0.32% | 31.22% | 68.84% | -4.27% | 87.37% |
Becton, Dickinson And Company | -0.45% | -1.02% | -6.88% | 0.23% | -3.91% |
West Pharmaceutical Services Inc | -1.31% | -22.47% | -18.62% | -26.76% | 114.12% |
Alcon Ag | 4.57% | 19.02% | 34.87% | 27.87% | 76.61% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Teleflex Incorporated | 44.23 | 44.23 | 1.32 | 13.97 | 0.06 | 0.03 | 0.01 | 96.76 |
Intuitive Surgical, Inc. | 83.28 | 83.28 | 4.2 | 6.65 | 0.16 | 0.08 | NA | 41.4 |
Resmed Inc. | 35.23 | 35.23 | 2.05 | 7.71 | 0.23 | 0.13 | 0.01 | 33.11 |
Becton, Dickinson And Company | 48.22 | 48.22 | 1.11 | 13.11 | 0.06 | 0.03 | 0.02 | 89.5 |
West Pharmaceutical Services Inc | 44.27 | 44.27 | 5.2 | 6.51 | 0.2 | 0.11 | 0.0 | 35.49 |
Alcon Ag | 44.88 | 44.88 | 3.71 | 3.05 | 0.05 | 0.03 | 0.0 | 42.35 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Teleflex Incorporated | Hold | $11.6B | -25.59% | 44.23 | 8.76% |
Intuitive Surgical, Inc. | Buy | $172.8B | 183.93% | 83.28 | 27.65% |
Resmed Inc. | Buy | $35.9B | 87.37% | 35.23 | 21.79% |
Becton, Dickinson And Company | Buy | $69.7B | -3.91% | 48.22 | 7.13% |
West Pharmaceutical Services Inc | Buy | $22.6B | 114.12% | 44.27 | 18.25% |
Alcon Ag | Buy | $49.3B | 76.61% | 44.88 | 11.44% |
Insights on Teleflex Incorporated
Revenue is up for the last 2 quarters, 737.84M → 749.69M (in $), with an average increase of 1.6% per quarter
Netprofit is up for the last 2 quarters, 15.28M → 80.03M (in $), with an average increase of 80.9% per quarter
In the last 1 year, Intuitive Surgical, Inc. has given 70.6% return, outperforming this stock by 42.8%
In the last 3 years, Intuitive Surgical, Inc. has given 46.0% return, outperforming this stock by 81.5%
T. Rowe Price Investment Management,Inc.
Vanguard Group Inc
HHG PLC
BlackRock Inc
Morgan Stanley - Brokerage Accounts
State Street Corp
In the quarter ending March,2024. Teleflex Incorporated has declared dividend of $0.34
Read Moreteleflex is a leading global provider of specialty medical devices for a range of procedures in critical care and surgery. our mission is to provide solutions that enable healthcare providers to improve outcomes and enhance patient and provider safety. headquartered in wayne, pa, teleflex employs approximately 12,000 people worldwide and serves healthcare providers in more than 150 countries.
Organization | Teleflex Incorporated |
Employees | 14500 |
CEO | Mr. Liam J. Kelly |
Industry | Health Technology |